Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente

Busca Global no Portal

Foram encontrados: 3222 Resultados

Kinkel K. The never-ending success story of BI-RADS. Diagn Interv Imaging. 2017 Mar;98(3):177-178. doi: 10.1016/j.diii.2017.02.003. PubMed PMID: 28262125. Any physician who wants to become familiar with the Breast Imaging Reporting and Data system (BI-RADS) will discover more than 1600 papers on Pub Med. What makes another paper about BI-RADS interesting? Hasn’t everything already been written about the subject? The paper published in this issue of Diagnostic & Interventional Imaging by Spak et al. summarizes the most recent changes in the fifth and latest edition of the BI-RADS. It represents a quick help in daily practice to keep the radiologist updated on the appropriate use of words and what to include in a clearly written breast imaging report.The effort to adapt a common language took also place among different breast imaging modalities. Spak et al. mention that the latest BI-RADS edition includes an extended description of lesion localization in the mammography section to make comparison with the MRI localization easier [1]. This edition also took great care to simplify mass description across different imaging modalities and avoid confusion as the language had been simplified and made more consistent between mammography, ultrasound and MRI. The purpose was to reduce differences in wording similar messages among imaging modalities. This can potentially help the radiologist in comparing imaging modalities to discriminate benign from malignant lesions or to correlate findings from one imaging modality to another. The Table 1 in Spak et al. paper is an ideal tool in any breast imaging reading room as it gives a quick overview of major changes between the 4th and the 5th edition.
El embarazo puede implicar riesgos importantes para la mujer. Las complicaciones propias de la gestación pueden derivar en graves secuelas o incluso la muerte de la madre y/o del feto trayendo consecuencias catastróficas para su entorno familiar y la sociedad en general. Cada día mueren en el mundo un promedio 800 mujeres por causas prevenibles relacionadas con el embarazo y el parto. De estas muertes el 99% ocurren en países en vías de desarrollo y la mayoría de ellas en zonas rurales. Hoy en día es claro que la atención oportuna y adecuada antes, durante y después del parto puede salvar la vida de muchas gestantes y recién nacidos. Es por esto que reducir la mortalidad infantil y mejorar la salud materna constituyen dos importantes indicadores de desarrollo de una región, definidos en el Objetivo sobre Salud y Desarrollo dentro de los Objetivos de Desarrollo Sostenible adoptados por la comunidad internacional en el año 2015. La meta establecida en los Objetivos del Milenio de lograr la disminución de la MM en un 75% a nivel mundial no fue alcanzada a pesar de una reducción del 44% de la mortalidad frente al indicador reportado en 1990. La región de Latinoamérica y el Caribe contribuye de manera importante con la mortalidad materna con una razón de 85 por cada 100.000 nacidos vivos y aunque estas estadísticas son cada vez más confiables, el sistema de registro de muchos de los países en latinoamérica continúa siendo deficiente. La hemorragia postparto constituye una verdadera emergencia obstétrica y su incidencia varía entre el 5 al 15% de nacimientos a nivel mundial. Además de causar muertes la mayoría de ellas prevenibles, produce un número importante de casos de morbilidad materna extrema (MME) o “casi muerte” representados por la necesidad de histerectomías, transfusión de hemoderivados, coagulopatía, choque hipovolémico y anemias severas que pueden terminar en daño permanente de órgano blanco. Debido a toda una serie de falencias en la atención y el cuidado materno en países en vías de desarrollo, el riesgo absoluto de muerte por HPP es mucho mayor que en países desarrollados (1 en 1000 vs. 1 en 100.000 respectivamente).
ommittee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-e186. doi: 10.1097/AOG.0000000000002351. PubMed PMID: 28937571. Maternal hemorrhage, defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process, remains the leading cause of maternal mortality worldwide (1). Additional important secondary sequelae from hemorrhage exist and include adult respiratory distress syndrome, shock, disseminated intravascular coagulation, acute renal failure, loss of fertility, and pituitary necrosis (Sheehan syndrome).Hemorrhage that leads to blood transfusion is the leading cause of severe maternal morbidity in the United States closely followed by disseminated intravascular coagulation (2). In the United States, the rate of postpartum hemorrhage increased 26% between 1994 and 2006 primarily because of increased rates of atony (3). In contrast, maternal mortality from postpartum obstetric hemorrhage has decreased since the late 1980s and accounted for slightly more than 10% of maternal mortalities (approximately 1.7 deaths per 100,000 live births) in 2009 (2, 4). This observed decrease in mortality is associated with increasing rates of transfusion and peripartum hysterectomy (2-4).The purpose of this Practice Bulletin is to discuss the risk factors for postpartum hemorrhage as well as its evaluation, prevention, and management. In addition, this document will encourage obstetrician-gynecologists and other obstetric care providers to play key roles in implementing standardized bundles of care (eg, policies, guidelines, and algorithms) for the management of postpartum hemorrhage.